InsiderTrades

Form 4 for PALI PALISADE BIO, INC.

Accepted 2024-02-08 00:00:00 ET · period of report 2024-02-06 · accession 0001493152-24-005480 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-02-08 2024-02-06 PALI Finley John David CEO, CFO, Dir M - OptEx $0.00 +6,642 88.1K +8% $0
DM 2024-02-08 2024-02-06 PALI Finley John David CEO, CFO, Dir M - OptEx — -6,642 34.8K -16% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.01 2024-02-06 M A 3,167 $0.00 91,291 D — — (F2) Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.
2 Common Common Stock, par value $0.01 2024-02-06 M A 3,475 $0.00 88,124 D — — (F1) Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on February 6, 2023.
3 Derivative Restricted Stock Units 2024-02-06 M D 3,475 — 27,800 D — · — to — 3,475 Common Stock (F5) This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on February 6, 2024, and an additional 27,800 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. (F4) Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
4 Derivative Restricted Stock Units 2024-02-06 M D 3,167 — 34,833 D — · — to — 3,167 Common Stock (F6) This restricted stock unit was granted on November 21, 2023 and 3,167 restricted stock units subject to the award vested on February 6, 2024 and an additional 34,833 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. (F4) Each restricted stock unit represents the right to receive, at settlement, one share of common stock.